Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Capital Reinvestment Ratio
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Capital Reinvestment Ratio of 0.18x as of December 2025, meaning it reinvests 0% of its operating cash flow (CN¥837.18 Million) in capital expenditures (CN¥152.89 Million). See 301408 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Capital Reinvestment Ratio (2021–2025)
This chart tracks Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A's Capital Reinvestment Ratio across 5 annual periods. Check 301408 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year Capital Reinvestment Ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A from 2021 to 2025. For live market cap and broader valuation context, see 301408 market cap overview.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | CN¥837.18 Million | CN¥152.89 Million | ▼ -35.1% |
| 2024 | 0.28x | CN¥571.76 Million | CN¥160.89 Million | ▼ -82.9% |
| 2023 | 1.65x | CN¥131.37 Million | CN¥216.31 Million | ▲ +173.2% |
| 2022 | 0.60x | CN¥173.84 Million | CN¥104.77 Million | ▲ +150.3% |
| 2021 | 0.24x | CN¥140.82 Million | CN¥33.91 Million | — |